Literature DB >> 17276934

Closed-tube SNP genotyping without labeled probes/a comparison between unlabeled probe and amplicon melting.

Michael Liew1, Michael Seipp, Jacob Durtschi, Rebecca L Margraf, Shale Dames, Maria Erali, Karl Voelkerding, Carl Wittwer.   

Abstract

Two methods for closed-tube single nucleotide polymorphism (SNP) genotyping without labeled probes have become available: unlabeled probe and amplicon melting. Unlabeled probe and amplicon melting assays were compared using 5 SNPs: human platelet antigens 1, 2, 5, and 15 and a C>T variant located 13910 base pairs (bp) upstream of the lactase gene. LCGreen Plus (Idaho Technology, Salt Lake City, UT) was used as the saturating DNA dye. Unlabeled probe data were readily interpretable and accurate for all amplicon lengths tested. Five targets that ranged in size from 42 to 72 bp were well resolved by amplicon melting on the LightScanner (Idaho Technology) or LightTyper (Roche, Indianapolis, IN) with no errors in genotyping. However, when larger amplicons (206 bp) were used and analyzed on lower resolution instruments (LightTyper and I-Cycler, Bio-Rad, Hercules, CA), the accuracy of amplicon genotyping was only 73% to 77%. When 2 temperature standards were used to bracket the amplicon of interest, the accuracy of amplicon genotyping of SNPs was increased to 100% (LightTyper) and 88% (I-Cycler).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17276934     DOI: 10.1309/N7RARXH3623AVKDV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Automated DNA extraction, quantification, dilution, and PCR preparation for genotyping by high-resolution melting.

Authors:  Michael T Seipp; Mark Herrmann; Carl T Wittwer
Journal:  J Biomol Tech       Date:  2010-12

2.  LightCycler technology in molecular diagnostics.

Authors:  Elaine Lyon; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2009-02-05       Impact factor: 5.568

3.  Genotyping of frequent BRCA1/2 SNPs with unlabeled probes: a supplement to HRMCA mutation scanning, allowing the strong reduction of sequencing burden.

Authors:  Kim De Leeneer; Ilse Coene; Bruce Poppe; Anne De Paepe; Kathleen Claes
Journal:  J Mol Diagn       Date:  2009-07-30       Impact factor: 5.568

Review 4.  High resolution melting applications for clinical laboratory medicine.

Authors:  Maria Erali; Karl V Voelkerding; Carl T Wittwer
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

5.  Multiplex amplicon genotyping by high-resolution melting.

Authors:  Michael T Seipp; Jacob D Durtschi; Karl V Voelkerding; Carl T Wittwer
Journal:  J Biomol Tech       Date:  2009-07

6.  Detection of the JAK2 mutation in myeloproliferative neoplasms by asymmetric PCR with unlabeled probe and high-resolution melt analysis.

Authors:  Hong-Cui Cao; Jiang Lin; Jun Qian; Dong-Ming Yao; Yun Li; Jing Yang; Qin Chen; Hai-Yan Chai; Gao-Fei Xiao
Journal:  J Clin Lab Anal       Date:  2011       Impact factor: 2.352

7.  Nucleotide extension genotyping by high-resolution melting.

Authors:  Michael Liew; Carl Wittwer; Karl V Voelkerding
Journal:  J Mol Diagn       Date:  2010-09-16       Impact factor: 5.568

8.  Development of high-resolution melting (HRM) analysis for population studies of Fascioloides magna (Trematoda: Fasciolidae), the giant liver fluke of ruminants.

Authors:  Ján Radvánský; Eva Bazsalovicsová; Ivica Králová-Hromadová; Gabriel Minárik; Ludevít Kádaši
Journal:  Parasitol Res       Date:  2010-10-22       Impact factor: 2.289

9.  Molecular typing for the Indian blood group associated 252G>C single nucleotide polymorphism in a selected cohort of Australian blood donors.

Authors:  Genghis H Lopez; Rhiannon S Mcbean; Brett Wilson; Darryl L Irwin; Yew-Wah Liew; Catherine A Hyland; Robert L Flower
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

10.  Rapid diagnosis of MEN2B using unlabeled probe melting analysis and the LightCycler 480 instrument.

Authors:  Rebecca L Margraf; Rong Mao; Carl T Wittwer
Journal:  J Mol Diagn       Date:  2008-02-07       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.